« Back to Record
Citation APA

Paridaens, R., Dirix, L. Y., Lohrisch, C., Beex, L., Nooij, M., Cameron, D. A., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., Lobelle, J. P., Piccart-Gebhart, M., & European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC), (2003). Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Annals of oncology, 14(9), 1391-1398. doi:10.1093/annonc/mdg362


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55258

Paridaens, R., Dirix, L. Y., Lohrisch, C., Beex, L., Nooij, M., Cameron, D. A., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., Lobelle, J. P., Piccart-Gebhart, M., & European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC), (2003). Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Annals of oncology, 14(9), 1391-1398. doi:10.1093/annonc/mdg362